top of page

The Head of Bayer in the US on pharma and a new $250M cell Tx facility in Berkeley, CA. #HLTH2023

Sebastian Guth discusses areas of focus for Bayer like oncology, cardiovascular disease, and women's health, and platforms such as radiopharmaceuticals and cell therapies. He also talks about investing in a new 100,000 square foot cell therapy manufacturing plant in Berkeley, CA.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page